Ginkgo Bioworks (DNA)
(Delayed Data from NYSE)
$0.27 USD
-0.02 (-5.46%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $0.27 0.00 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | 0.00% |
ABR | 3.83 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.29 |
Next Year | -0.18 |
EPS (TTM) | -0.34 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 45.64M | 50.11M | NA | 219.09M |
# of Estimates | 2 | 2 | NA | 2 |
High Estimate | 46.00M | 52.22M | NA | 220.17M |
Low Estimate | 45.28M | 48.00M | NA | 218.00M |
Year ago Sales | 55.43M | 34.76M | 251.46M | NA |
Year over Year Growth Est. | -17.66% | 44.16% | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | -0.06 | -0.29 | -0.18 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.07 | -0.06 | -0.27 | -0.16 |
Low Estimate | -0.07 | -0.06 | -0.30 | -0.19 |
Year ago EPS | -0.09 | -0.09 | -0.39 | -0.29 |
Year over Year Growth Est. | 22.22% | 33.33% | 25.64% | 37.93% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | -0.06 | -0.29 | -0.18 |
7 Days Ago | -0.07 | -0.06 | -0.29 | -0.18 |
30 Days Ago | -0.08 | -0.07 | -0.30 | -0.22 |
60 Days Ago | -0.08 | -0.07 | -0.30 | -0.22 |
90 Days Ago | -0.08 | -0.08 | -0.31 | -0.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.07 | -0.06 | -0.29 | -0.18 |
Zacks Consensus Estimate | -0.07 | -0.06 | -0.29 | -0.18 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.08 | -0.09 | -0.09 | NA |
Estimate | -0.08 | -0.08 | -0.09 | -0.09 | NA |
Difference | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more